
Sergey Kravtsov
Ask VT AI
View News Summary
- Controversial officiating in Eagles-Giants game sparks calls to revisit 'tush push' rule
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Hong Kong court sentences trio for conspiring to carry out bomb attacks in 2019-2020, with the aim of forcing the government to close borders early in the COVID-19 pandemic.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Controversial officiating in Eagles-Giants game sparks calls to revisit 'tush push' rule
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Hong Kong court sentences trio for conspiring to carry out bomb attacks in 2019-2020, with the aim of forcing the government to close borders early in the COVID-19 pandemic.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Sergey Kravtsov
News from Sergey Kravtsov
